Alaa Hosny

Alaa Hosny

Head of Development

Subject Expert
About

Alaa Hosny has over 15 years of experience in the pharmaceutical industry, specializing in drug product development from early formulation design through clinical implementation. In his role as Head of Development, Alaa leads development teams and collaborates across functions to deliver complex projects efficiently and on time, driving results through strategic planning and technical expertise.

Alaa’s experience spans enabling technologies such as lipid-based formulations and spray drying, as well as modified-release dosage forms. He has a strong track record in developing innovative solutions for challenging molecules, optimizing bioavailability, and ensuring robust product performance. Prior to Quotient Sciences, Alaa gained experience in development and scale-up of generic formulations for commercial manufacturing.

Alaa holds an MSc in Drug Delivery from Aston University and has a deep interest in advancing formulation strategies that accelerate the path from concept to clinic.

Latest news from Quotient Sciences

More News
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline By: Dr. Andrew Lewis
Read More
News & Announcements, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences shortlisted for "Best Use of AI in Clinical Development & Trial Innovation" at the Scrip Awards 2026 By: Dr. Andrew Lewis
Read More